NEU 0.10% $19.88 neuren pharmaceuticals limited

Acadia, page-678

  1. 562 Posts.
    lightbulb Created with Sketch. 298

    A Citigroup analyst initiated coverage on Acadia with a Buy rating and announced a price target of $38. Additionally the US District Court for the District of Delaware has issued a summary judgment in favor of Acadia, affirming the validity of the NUPLAZID (pimavanserin) '740 composition of matter patent on all grounds
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.88
Change
-0.020(0.10%)
Mkt cap ! $2.552B
Open High Low Value Volume
$20.22 $20.44 $19.85 $2.961M 147.8K

Buyers (Bids)

No. Vol. Price($)
1 4015 $21.34
 

Sellers (Offers)

Price($) Vol. No.
$17.90 71 1
View Market Depth
Last trade - 15.59pm 04/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.